Accumulating evidence suggests that elevated muscarinic acetylcholine receptor (mAChR)-mediated signaling and metabotropic glutamate receptor5 (mGluR5)-mediated signaling are involved in the pathogenesis of FXS [5–7]. This evidence concerns the gene GRM5 and fragile X syndrome.